MRC Laboratory of Molecular Biology
One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.
Andres Floto’s group in the University of Cambridge’s Molecular Immunity Unit, housed at the LMB, have developed phenogenomic analysis – a combination of phenotyping and whole genome sequencing – as a new approach to reveal insights into bacterial pathobiology.
Structural study by Nigel Unwin in the LMB’s Neurobiology Division, has found that lipids of cell membranes can form ordered, hydrophobic ‘skins’ in regions of high cholesterol concentration.
New research from Lalita Ramakrishnan’s group, LMB Cell Biology Division and University of Cambridge Molecular Immunity Unit, has revealed the reverse electron transport pathway behind mitochondrial reactive oxygen species overproduction, contributing to tuberculosis pathogenesis.
A clinical study, led by Nina Rzechorzek in John O’Neill’s group at the LMB, showed that healthy human brain temperature varies far more than previously assumed—by age, sex, brain region, and time of day. This has major implications for patients, suggesting that daily rhythmic brain temperature variation is critical to brain function.
Andrew McKenzie’s group, in the LMB’s PNAC Division, has found a link between tumour-related expression of the IL25 gene, innate lymphoid cells and reduced survival amongst colorectal cancer patients
A new study from Joe Yeeles’ group, in the LMB’s PNAC Division, demonstrates the first reconstitution of a functional human replisome that performs fast and efficient DNA replication.